Cite
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
MLA
Judith Trotman, et al. “Early Treatment Intensification with R-ICE and 90Y-Ibritumomab Tiuxetan (Zevalin)-BEAM Stem Cell Transplantation in Patients with High-Risk Diffuse Large B-Cell Lymphoma Patients and Positive Interim PET after 4 Cycles of R-CHOP-14.” Haematologica, vol. 102, Nov. 2016, pp. 356–63. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....029a8651745f381082fff4950817af13&authtype=sso&custid=ns315887.
APA
Judith Trotman, Gavin Cull, Amanda Johnston, Mark Hertzberg, Ian D. Lewis, Shir-Jing Ho, Pauline Warburton, Andrew Wirth, Devinder Gill, John Taper, Anne-Marie Watson, Sam Milliken, Michael S Hofman, Keith Fay, Rodney J. Hicks, Belinda Butcher, John F Seymour, Andrew Grigg, Maher K. Gandhi, … William Renwick. (2016). Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14. Haematologica, 102, 356–363.
Chicago
Judith Trotman, Gavin Cull, Amanda Johnston, Mark Hertzberg, Ian D. Lewis, Shir-Jing Ho, Pauline Warburton, et al. 2016. “Early Treatment Intensification with R-ICE and 90Y-Ibritumomab Tiuxetan (Zevalin)-BEAM Stem Cell Transplantation in Patients with High-Risk Diffuse Large B-Cell Lymphoma Patients and Positive Interim PET after 4 Cycles of R-CHOP-14.” Haematologica 102 (November): 356–63. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....029a8651745f381082fff4950817af13&authtype=sso&custid=ns315887.